跳至主要内容
临床试验/jRCT1040240055
jRCT1040240055已完成不适用

Development of a telemedicine system for dementia - An exploratory study of the usefulness of Carebee, a telecommunication tool for people with dementia.

National Center for Geriatrics and Gerontology0 个研究点目标入组 15 人开始时间: 2023年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Health Services Research
盲法
Open(masking Not Used)

入排标准

年龄范围
65age old over 至 95age old not(—)
性别
All

入选标准

  • Persons with dementia (the person in question)
  • Age: 65 years old or older and less than 95 years old (at the time of obtaining consent). The age of the caregiver is not required.
  • Medical examination category: Outpatients. Patients must have been diagnosed with dementia while attending the outpatient clinic of the National Institute for Longevity Sciences. The type of dementia does not matter.
  • Must be accompanied by a reliable caregiver for the duration of the study and must give written consent (a reliable caregiver must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study).
  • MMSE of at least 11 points within 6 months prior to consent.
  • Patients who have given their written consent to participate in the study.
  • The line condition must be 1.7 Gbps to 1 Gbps maximum transmission speed at the time of reception.
  • Any age.
  • Must be physically and mentally healthy, have contact with the subject for at least one hour per week, and be able to participate in all interventions until the end of the study by the same person.
  • Written consent to participate in the study must be obtained from the caregiver.

排除标准

  • Has severe hearing impairment, dysarthria, or aphasia.
  • Patients who are inconvenienced by the communication status of their smartphones in their home environment.
  • Other patients who are deemed inappropriate by the principal investigator and the subinvestigator.

结局指标

主要结局

-

Percentage of continued use of the system during the first 4 weeks of intervention.

次要结局

  • Percentage of continued use of the system(8 weeks after the start of the intervention)
  • Time assisted to start using the system(4 weeks of intervention)

研究者

相似试验

Carebee Study | 临床试验